BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs4950928
,
FGF21
,
T cell differentiation
,
Breast Cancer
,
Retina
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
inactivation of MAPK activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Brucellosis
Vesicular stomatitis Indiana virus disease
Peritoneal foreign body
Pyloric ulcer
Behavior finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
foretinib
flavopiridol
B-Cell Activation Factor Receptor
ARQ 197
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EXO1
SRSF2
NCL
CTSK
PLXNA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Colon carcinoma CW2 cells treated with small molecule perturbagens
The Immunological Genome Project - Immune cell lineage differentiation and maturation
L1000 CMAP - Kidney epithelial HA1E.311 cells with CRISPR targeted gene knockouts
Fibroblasts serum starved treated with anisomycin for 3 or 6hr with or without H89 pre-treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for inactivation of MAPK activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Topical Bimatoprost for Chemical Blepharoplasty
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Can…
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ